Presentation ACC 2021

Benefits of SGLT1/2 Inhibition with Sotagliflozin in Heart Failure With Preserved Ejection Fraction

Presenter: Deepak L. Bhatt

May 17, 2021

REGISTER for free or LOG IN to view this content

Benefits of SGLT1/2 Inhibition with Sotagliflozin in Heart Failure With Preserved Ejection Fraction

Heart Failure

Presentation

ACC 2021

SGLT1/2

sotagliflozin

Up Next

Presentation ACC 2021

Randomized trial of high sensitivity Troponin T in the Emergency Department

Presenter: Derek Chew

May 18, 2021

More slides +

Presentation TVT 2021

Long-term Data Updates on RCTs in PFO Closure

Presenter: John Rhodes

July 22, 2021

Presentation TVT 2021

Characterizing the Transcatheter Clinical Need: Prevalence of Severe AR and Surgical Alternatives

Presenter: Vinod Thourani

July 21, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.